A reliable large-scale design space was constructed by integrating the reliability of a scale-up rule into the Bayesian estimation without enforcing a large-scale design of experiments (DoE). A small-scale DoE was conducted using various Froude numbers (X 1 ) and blending times (X 2 ) in the lubricant blending process for theophylline tablets. The response surfaces, design space, and their reliability of the compression rate of the powder mixture (Y 1 ), tablet hardness (Y 2 ), and dissolution rate (Y 3 ) on a small scale were calculated using multivariate spline interpolation, a bootstrap resampling technique, and self-organizing map clustering. A constant Froude number was applied as a scale-up rule. Experiments were conducted at four different small scales with the same Froude number and blending time in order to determine the discrepancies in the response variables between the scales so as to indicate the reliability of the scale-up rule. Three experiments under an optimal condition and two experiments under other conditions were performed on a large scale. The response surfaces on the small scale were corrected to those on the large scale by Bayesian estimation using the large-scale results and the reliability of the scale-up rule. Large-scale experiments performed under three additional sets of conditions showed that the corrected design space was more reliable than the small-scale design space even when there was some discrepancy in the pharmaceutical quality between the manufacturing scales. This approach is useful for setting up a design space in pharmaceutical development when a DoE cannot be performed at a commercial large manufacturing scale.
Key words quality by design; design of experiments; multivariate regression; modelingThe international conference on harmonization (ICH) 1) outlined quality by design (QbD) as a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management. The QbD principle implies that pharmaceutical quality should not be tested using day-to-day release testing but should be elaborated by design in advance. One of the most significant approaches in the QbD concept is the establishment of a design space based on a multidimensional combination of input formulation parameters, process parameters, or material attributes that provide assurance of quality attributes.
2)Design of experiments (DoE) studies 3,4) have been used effectively to construct design spaces. DoE is a useful method for systematic understanding of the relationship between input parameters and output quality attributes. A typical design space is established as a superposition of the response surfaces for each quality attribute generated by the response surface method (RSM) using the DoE results.5-11) The RSM includes statistical analyses such as multiple linear regression analysis 12) and artificial neural networks. 13) Takayama et al. developed a novel RSM that incorporates multivar...